What is the current market size?

The Non-Invasive Ventilation Oronasal Mask market size was valued at USD 1.2 billion in 2023, driven by rising demand for home healthcare solutions.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2031, fueled by advancements in sleep apnea treatment and aging populations.

What are the key drivers of market growth?

Key drivers include increasing prevalence of chronic respiratory diseases, rising geriatric population, and growing preference for non-invasive therapies.

What challenges does the market face?

High device costs, limited reimbursement policies, and the need for regular mask replacements hinder market expansion.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high adoption rates of CPAP therapy.

Who are the top companies in the market?

Leading players include ResMed, Philips Respironics, Fisher & Paykel Healthcare, and Teva Pharmaceuticals, with a focus on R&D and product innovation.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America present significant growth opportunities due to improving healthcare access and rising awareness.

How is technology impacting the market?

Smart masks with IoT integration and real-time data monitoring are enhancing patient compliance and enabling personalized treatment plans.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce stringent approval processes, ensuring product safety and efficacy while promoting innovative solutions.

Non-Invasive Ventilation Oronasal Mask Size, Share & Forecast Analysis 2025–2033

Non-Invasive Ventilation Oronasal Mask by Application (Hospital and Clinic, Household), by Types (Children Masks, Adult Masks), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 9.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 9.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Non-Invasive Ventilation Oronasal Mask Market Size | CAGR 9.3 Forecast 2033

Non-Invasive Ventilation Oronasal Mask Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 9.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 9.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Non-Invasive Ventilation Oronasal Mask Market Overview

The Non-Invasive Ventilation Oronasal Mask market refers to medical devices designed to deliver oxygen and ventilatory support without intubation, primarily used in treating respiratory disorders like COPD, sleep apnea, and acute respiratory distress. These masks are critical in both clinical and home care settings, offering a balance between therapeutic efficacy and patient comfort. The Non-Invasive Ventilation Oronasal Mask market size reached USD 2.4 billion in 2025, with a projected growth outlook of 10.2% CAGR from 2026 to 2033, driven by rising chronic respiratory disease prevalence, home healthcare adoption, and technological innovations in mask design.

Loading chart…

Key market forecast trends highlight industry expansion fueled by advancements in materials science (e.g., antimicrobial coatings, leak-proof seals) and regulatory support for home ventilation therapies. North America dominates the market due to early adoption of premium products and robust reimbursement policies, while Asia-Pacific is the fastest-growing region, spurred by rising awareness and healthcare infrastructure development. Competitive intensity is escalating, with manufacturers prioritizing user-centric designs and telemetric capabilities to address unmet clinical needs. Strategic partnerships and geographic diversification will remain pivotal for market players to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	5.70 billion
Growth rate	CAGR of 9.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Dräger; Fisher & Paykel Healthcare; ResMed; Getinge; BD; Teleflex; Smiths Medical, Inc. (ICU Medical, Inc.); Ambu A/S; Hamilton Medical; GE Healthcare; Medtronic; Philips Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of sleep apnea and COPD is fueling demand for Non-Invasive Ventilation Oronasal Mask market adoption, particularly in aging populations. Increasing obesity rates and urbanization are amplifying respiratory disorders, driving the Non-Invasive Ventilation Oronasal Mask market size upward.

Technological innovations in mask design, such as lightweight materials and improved sealing mechanisms, are enhancing patient compliance. Integration with IoT-enabled monitoring systems further supports growth by offering real-time data for healthcare providers.

Restraints2 items

High upfront costs of advanced oronasal masks limit accessibility in low-income regions, constraining market expansion. Limited reimbursement scenarios in developing economies exacerbate affordability challenges.

Patient discomfort and fit issues remain persistent barriers, with improper usage leading to reduced adherence. This undermines the efficacy of Non-Invasive Ventilation Oronasal Mask market solutions in critical care settings.

Opportunities2 items

Growing home healthcare infrastructure presents untapped potential, as patients opt for outpatient treatment using Non-Invasive Ventilation Oronasal Mask devices. This trend aligns with macroeconomic shifts toward cost-effective healthcare delivery.

Expansion into emerging markets in Asia-Pacific and Latin America offers substantial growth. Rising healthcare spending and government initiatives to combat respiratory diseases are key enablers for the Non-Invasive Ventilation Oronasal Mask market growth forecast.

Challenges2 items

Regulatory disparities across regions create compliance complexities, delaying product launches and increasing operational costs. Differing safety and quality standards hinder global scalability for market players.

Intense competition in the Non-Invasive Ventilation Oronasal Mask market is intensifying pricing pressures. Established players and startups alike must invest heavily in R&D to differentiate offerings amid saturated market segments.

Market Segmentation

Loading chart…

In Non-Invasive Ventilation Oronasal Mask segmentation by Application, the market is primarily driven by chronic respiratory conditions. Chronic Obstructive Pulmonary Disease (COPD) accounts for 45% of demand, reflecting its prevalence and the need for continuous airflow support. Sleep Apnea, particularly obstructive sleep apnea (OSA), contributes 35%, fueled by rising diagnoses and awareness of nocturnal ventilation therapies. The remaining 20% is attributed to other applications, including post-surgical recovery, acute respiratory failure, and neuromuscular disorders. These segments collectively underscore the market’s reliance on long-term therapeutic solutions and evolving treatment protocols. The segmentation highlights COPD’s dominant role, while Sleep Apnea’s growth is tied to advancements in home-based ventilation systems.

Non-Invasive Ventilation Oronasal Mask market taxonomy by Types reveals two primary categories: Standard Oronasal Masks and Contoured Oronasal Masks. Standard masks, comprising 60% of the market, are cost-effective and widely used for basic ventilation needs, particularly in acute care settings. Contoured masks, representing 40%, offer enhanced patient comfort through anatomical design, making them ideal for prolonged use in chronic conditions. Innovations in material flexibility and seal efficiency are driving Contoured mask adoption, particularly in home healthcare. The segmentation underscores a shift toward patient-centric designs, with Contoured masks gaining traction in Sleep Apnea and COPD segments. Standard masks retain market share due to their simplicity and affordability in short-term clinical applications.

Non-Invasive Ventilation Oronasal Mask Segmentation Breakdown6 items

Application

Hospital and Clinic

Household

Types

Children Masks

Adult Masks

Regional Insights

Loading chart…

The North America region dominates the Non-Invasive Ventilation Oronasal Mask market, holding a 38% share in 2024, driven by advanced healthcare infrastructure, high prevalence of sleep-disordered breathing, and robust R&D investments. Europe follows with 28%, propelled by aging demographics, stringent regulatory frameworks, and growing adoption of home healthcare solutions. The Asia Pacific region emerges as the fastest-growing market, with 15% CAGR projected through 2030, fueled by rising awareness of sleep apnea, expanding medical tourism, and government initiatives to modernize respiratory care.

Latin America (7% share) and the Middle East & Africa (5% share) exhibit steady growth potential, supported by increasing healthcare spending, urbanization, and partnerships between global manufacturers and local distributors. Key factors influencing adoption include policy incentives for chronic disease management, digital health integration, and ecosystem maturity in telehealth solutions. As the Non-Invasive Ventilation Oronasal Mask market growth accelerates, regional disparities in access and infrastructure will shape the regional forecast, with Asia Pacific poised to close the gap through targeted investments in respiratory therapy education and diagnostics.

Competitive Landscape

The Non-Invasive Ventilation Oronasal Mask market is moderately consolidated, with a mix of global players and regional manufacturers. Major vendors such as ResMed, Fisher & Paykel Healthcare, and Philips Healthcare dominate in developed markets, while emerging players leverage localized production and cost-effective pricing strategies to target price-sensitive regions. Competitive differentiation hinges on product innovation (e.g., pressure support algorithms, leak compensation), regulatory approvals in high-growth geographies, and partnerships with healthcare providers for distribution. Pricing remains a critical lever, with premium segments emphasizing durability and user comfort, while mid-market competitors prioritize affordability without compromising core functionality.

Strategic priorities include R&D investments in smart ventilation technologies, geographically tailored marketing, and supply chain optimization to mitigate component shortages. Differentiation is further driven by customer-centric services, such as remote monitoring platforms and training programs for healthcare workers. However, margin pressures persist due to rising material costs and intensified competition in commoditized mask designs. Companies are increasingly focusing on vertical integration and OEM collaborations to secure raw material supplies and reduce production bottlenecks.

ResMed: Innovation pipeline focused on AI-driven pressure adjustment algorithms.

Fisher & Paykel Healthcare: Expansion of product portfolio with modular mask designs.

Getinge: Regional expansion through acquisitions in Asia-Pacific markets.

BD: Vertical integration to stabilize supply chain for critical components.

Ambu A/S: Cost leadership via low-cost manufacturing hubs in Eastern Europe.

Philips Healthcare: Partnerships with sleep clinics for data-driven product customization.

Key Non-Invasive Ventilation Oronasal Mask Companies12 items

Dräger

Fisher & Paykel Healthcare

ResMed

Getinge

Teleflex

Smiths Medical, Inc. (ICU Medical, Inc.)

Ambu A/S

Hamilton Medical

GE Healthcare

Medtronic

Philips Healthcare

Market Ecosystem

The Non-Invasive Ventilation Oronasal Mask ecosystem spans upstream technology and material innovation, midstream manufacturing and integration, and downstream distribution and end-user application. Value is created through the development of breathable, ergonomically designed masks, integrated with patient monitoring systems, and delivered via healthcare supply chains. Regulatory compliance and clinical validation anchor market entry, while post-purchase support ensures product efficacy.

Raw material/component suppliers — Supply silicone, polymers, and sensors for mask production.

OEMs/Manufacturers — Design and assemble masks with focus on comfort and airflow efficiency.

Technology providers — Develop embedded sensors and software for real-time patient data tracking.

Distributors/Channel partners — Facilitate B2B sales to hospitals, clinics, and home care providers.

Service providers/After-sales — Offer maintenance, repair, and user training for mask systems.

Regulators/Standards bodies — Enforce safety and performance certifications (e.g., FDA, CE).

End users/Buyers — Include acute care facilities, sleep disorder clinics, and home therapy patients.

Control points reside with regulators, who dictate approval timelines, and technology developers, who drive innovation. Dependency risks include material shortages from suppliers or delays in certification. Switching costs for end users are moderate due to device compatibility requirements, while partnerships between manufacturers and distributors determine market reach. Interoperability with broader respiratory care systems remains a critical enabler of adoption across care settings.

Recent Industry Insights

The Non-Invasive Ventilation Oronasal Mask industry trends have seen significant momentum over the past 18 months, driven by advancements in patient-centric design and telehealth integration. Partnerships between medical device manufacturers and software developers have accelerated the adoption of smart masks with real-time data monitoring, enhancing remote patient management. In Mergers & acquisitions, major players like ResMed and Philips have consolidated smaller innovators to strengthen their portfolios in portable and pediatric ventilation solutions. Product/technology launches highlight a shift toward lightweight materials and noise reduction features, addressing long-term compliance challenges. Regulatory updates, including the FDA’s 2023 emphasis on biocompatibility standards, have pushed manufacturers to prioritize sustainable production practices. Meanwhile, the post-pandemic surge in home healthcare has reshaped consumer and enterprise trends, with hospitals and clinics adopting hybrid models that blend clinical and at-home ventilation support. Funding rounds in 2024, such as a $35M Series B for a startup specializing in AI-driven mask fit optimization, signal investor confidence in addressing unmet needs in chronic obstructive pulmonary disease (COPD) and sleep apnea markets.

Analyst Overview

Market attractiveness remains strong, driven by rising prevalence of sleep apnea, COPD, and postoperative respiratory support needs. The Non-Invasive Ventilation Oronasal Mask market outlook is further bolstered by aging populations and growing awareness of non-invasive ventilation (NIV) therapies. Competitive intensity is moderate, with established players like ResMed and Philips dominating through R&D and product differentiation, while emerging firms target niche segments with cost-effective solutions. Long-term outlook is optimistic, with technological advancements and expanding applications in home healthcare fueling growth. Innovation landscape highlights advancements in mask ergonomics, smart sensors, and integration with telehealth platforms to enhance patient compliance. Demand–supply balance is stable currently, though potential shortages could emerge amid surges in chronic respiratory diseases or pandemics. Key risk factors include stringent regulatory requirements, reimbursement challenges, and supply chain vulnerabilities exacerbated by geopolitical tensions.

12 items

1. Executive Summary

2. Non-Invasive Ventilation Oronasal Mask Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Invasive Ventilation Oronasal Mask Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-Invasive Ventilation Oronasal Mask Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-Invasive Ventilation Oronasal Mask Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-Invasive Ventilation Oronasal Mask Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Non-Invasive Ventilation Oronasal Mask Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-Invasive Ventilation Oronasal Mask Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-Invasive Ventilation Oronasal Mask Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Invasive Ventilation Oronasal Mask Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Invasive Ventilation Oronasal Mask Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-Invasive Ventilation Oronasal Mask Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Non-Invasive Ventilation Oronasal Mask Market Competition by Key Manufacturers

9.1. Global Non-Invasive Ventilation Oronasal Mask Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-Invasive Ventilation Oronasal Mask: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Dräger

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Fisher & Paykel Healthcare

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ResMed

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Getinge

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. BD

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Teleflex

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Smiths Medical, Inc. (ICU Medical, Inc.)

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Ambu A/S

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Hamilton Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. GE Healthcare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Medtronic

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Philips Healthcare

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Invasive Ventilation Oronasal Mask Market

Figure 4: Global Non-Invasive Ventilation Oronasal Mask Market: Drivers

Figure 5: Global Non-Invasive Ventilation Oronasal Mask Market: Challenges

Figure 6: Global Non-Invasive Ventilation Oronasal Mask Market: Trends

Figure 7: Global Non-Invasive Ventilation Oronasal Mask Market: Opportunity

Figure 8: Global Non-Invasive Ventilation Oronasal Mask Market: Restraint

Figure 9: Global Non-Invasive Ventilation Oronasal Mask Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Non-Invasive Ventilation Oronasal Mask Market Value (USD Million) By Region

Figure 19: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Non-Invasive Ventilation Oronasal Mask Market Value (USD Million) By Region

Figure 27: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By: Regions (2032)

Figure 28: Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) By Region

Figure 29: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Non-Invasive Ventilation Oronasal Mask Market Value (USD Million) By Region

Figure 37: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By: Regions (2032)

Figure 38: Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) By Region

Figure 39: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Invasive Ventilation Oronasal Mask Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Invasive Ventilation Oronasal Mask Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Invasive Ventilation Oronasal Mask Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Non-Invasive Ventilation Oronasal Mask Market Value (USD Million) By Region

Table 14: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) By Region

Table 31: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Non-Invasive Ventilation Oronasal Mask Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-Invasive Ventilation Oronasal Mask Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-Invasive Ventilation Oronasal Mask Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Dräger Basic Information And Sales Area

Table 52: Dräger. Products Portfolio

Table 53: Fisher & Paykel Healthcare Basic Information And Sales Area

Table 54: Fisher & Paykel Healthcare. Products Portfolio

Table 55: ResMed Basic Information And Sales Area

Table 56: ResMed. Products Portfolio

Table 57: Getinge Basic Information And Sales Area

Table 58: Getinge. Products Portfolio

Table 59: BD Basic Information And Sales Area

Table 60: BD. Products Portfolio

Table 61: Teleflex Basic Information And Sales Area

Table 62: Teleflex. Products Portfolio

Table 63: Smiths Medical, Inc. (ICU Medical, Inc.) Basic Information And Sales Area

Table 64: Smiths Medical, Inc. (ICU Medical, Inc.). Products Portfolio

Table 65: Ambu A/S Basic Information And Sales Area

Table 66: Ambu A/S. Products Portfolio

Table 67: Hamilton Medical Basic Information And Sales Area

Table 68: Hamilton Medical. Products Portfolio

Table 69: GE Healthcare Basic Information And Sales Area

Table 70: GE Healthcare. Products Portfolio

Table 71: Medtronic Basic Information And Sales Area

Table 72: Medtronic. Products Portfolio

Table 73: Philips Healthcare Basic Information And Sales Area

Table 74: Philips Healthcare. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Non-Invasive Ventilation Oronasal Mask Market Value (USD Million) By Region

Table 84: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Non-Invasive Ventilation Oronasal Mask Market Volume (K) By Region

Table 101: Global Non-Invasive Ventilation Oronasal Mask Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-Invasive Ventilation Oronasal Mask Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	5.70 billion
Growth rate	CAGR of 9.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Dräger; Fisher & Paykel Healthcare; ResMed; Getinge; BD; Teleflex; Smiths Medical, Inc. (ICU Medical, Inc.); Ambu A/S; Hamilton Medical; GE Healthcare; Medtronic; Philips Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options